NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球抗衰老市場研究報告:按產品、治療、活力收入和需求預測 (-2030)

Anti-Aging Market Research Report: By Product, Treatment, Demography -Revenue Estimation and Demand Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 1023324
出版日期 內容資訊 英文 356 Pages
商品交期: 2-3個工作天內
價格
全球抗衰老市場研究報告:按產品、治療、活力收入和需求預測 (-2030) Anti-Aging Market Research Report: By Product, Treatment, Demography -Revenue Estimation and Demand Forecast to 2030
出版日期: 2021年06月01日內容資訊: 英文 356 Pages
簡介

2020年全球抗衰老市場規模達到1944億美元。預計到 2030 年將達到 4228 億美元,在 2021 年至 2030 年的預測期內,市場預計將以 8.6% 的複合年增長率增長。

推動市場增長的主要因素是通過學術團體和研討會提高產品意識、醫療旅遊領域的發展、抗衰老整容手術數量的增加以及全球可支配收入的增加。在2020年的抗衰老市場中,北美是最賺錢的。這是由於非手術美容治療的增加、護膚產品意識的提高以及加拿大和美國抗衰老治療的激增。到2030年,亞太地區的抗衰老市場預計將增長最快。不斷增長的老齡化人口也在推動該地區的市場發展,尋求治療與年齡有關的問題的趨勢越來越大。

本報告探討了全球抗衰老市場,並提供了有關市場分析、市場動態、區域市場規模和預測、競爭狀況、企業概況等方面的全面信息。

目錄

第 1 章調查背景

  • 調查目的
  • 市場定義
  • 調查範圍
    • 市場細分:按產品
    • 市場細分:按處理
    • 市場細分:按活力
    • 市場細分:按地區
    • 分析期
    • 市場數據報告單位
      • 價值
  • 主要利益相關者

第 2 章調查方法

  • 二次調查
  • 初步調查
    • 主要調查受訪者的細分
      • 按地區
      • 按行業進入者
      • 按公司類型
  • 估計市場規模
  • 數據三角剖分
  • 調查的先決條件

第 3 章執行摘要

第 4 章介紹

  • 細分市場的定義
    • 按產品
      • 抗皺
      • 頭髮顏色
      • 紫外線吸收
      • 抗妊娠紋
      • 其他
    • 按處理方法
      • 頭髮生長
      • 預防色素沉著
      • 成人痤瘡治療
      • 隆胸
      • 抽脂
      • 化學剝離
      • 其他
    • 按生命統計
      • X 世代
      • 嬰兒潮一代
      • Y 世代
      • Z世代
  • 市場動態
    • 趨勢
      • 消費者趨向於使用易於使用的家用抗衰老設備
    • 促進因素
      • 通過研討會和會議提高認識
      • 老年人口快速增加
      • 可支配收入增加
      • 技術進步
      • 不斷發展的醫療旅遊產業
      • 增加抗衰老美容用量
      • 增長因素對市場預測的影響分析
    • 抑制因素
      • 抗衰老設備成本高
      • 嚴格的監管要求
      • 與使用抗衰老設備相關的風險和副作用
      • 約束對市場預測的影響分析
    • 市場機會
      • 未滿足的微創或非侵入性治療需求
      • 更多地使用社交網絡和電子商務平台
  • COVID-19 的影響
  • 波特五力分析
    • 買方的議價能力
    • 供應商議價能力
    • 激烈的競爭
    • 新進入者的威脅
    • 替代威脅
  • 目標受眾 - 人口統計
    • 總人口:性別
    • 尋常癢疹的患病率:性別
    • 總人口:按年齡
    • 尋常癢疹患病率:按年齡
    • 嫩膚和抗衰老產品的目標人群:按年齡
    • 使用嫩膚和抗衰老產品的男性目標人群:按年齡
    • 使用嫩膚和抗衰老產品的女性目標人群:按年齡
  • 監管框架分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 就診抗衰老醫院的患者人數(2020 年)
    • 美國
    • 加拿大
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 瑞士
    • 日本
    • 中文
    • 印度
    • 韓國
    • 台灣
    • 新加坡
    • 馬來西亞
    • 巴西
    • 墨西哥
    • 沙特阿拉伯
  • 醫院提供的抗衰老程序類型及其費用
  • 醫院採用的商業模式
  • 醫院提供的抗衰老項目/套餐

第 5 章全球市場規模和預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按地區

第 6 章北美市場規模和預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按國家/地區
    • 美國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 加拿大抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計

第 7 章歐洲市場規模和預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按國家/地區
    • 德國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 英國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 法國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 意大利抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 西班牙抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 瑞士抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計

第 8 章亞太市場規模及預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按國家/地區
    • 日本抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 中國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 印度抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 韓國抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 台灣抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 新加坡抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 馬來西亞抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計

第 9 章拉丁美洲市場規模和預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按國家/地區
    • 巴西抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計
    • 墨西哥抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計

第 10 章中東和非洲的市場規模和預測

  • 按產品
    • 抗皺市場:按類型
  • 按處理方法
  • 按生命統計
  • 按國家/地區
    • 沙特阿拉伯的抗衰老市場
      • 按產品
      • 按處理方法
      • 按生命統計

第 11 章競爭形勢

  • 公司及其產品列表
  • 各大公司產品標桿
  • 大公司戰略發展
    • 併購
    • 設施擴建
    • 產品發佈和審批
    • 夥伴關係和合作
    • 其他開發

第 12 章公司簡介

  • The Procter & Gamble Company
  • Nu Skin Enterprises Inc.
  • Hologic Inc.
  • Unilever Group
  • Pierre Fabre S.A
  • Galderma SA
  • Shiseido Company Limited
  • Candela Corporation
  • Home Skinovations Ltd.
  • Allergan plc
  • The Estee Lauder Companies Inc.
  • Johnson & Johnson
  • Beiersdorf AG
  • L'Oreal SA
  • Orlane S.A.
  • Age Sciences Inc.
  • Coty Inc.
  • Alma Lasers Ltd.
  • Lumenis Ltd.
  • Panasonic Corporation
  • TRIA Beauty Inc.
  • Carol Cole Company Inc.
  • YA-MAN LTD.
  • MTG Co. Ltd.
  • Koninklijke Philips N.V.
  • LightStim
  • Spectrum Brands Holdings Inc.
  • Conair Corporation
  • Amorepacific Corporation
  • Project E Beauty
  • Dr. Dennis Gross Skincare LLC
  • Beauty Bioscience Inc.
  • FOREO AB
  • Cyden Limited
  • Jeisys Medical Inc.
  • Imdad LLC
  • Clarins Group
  • L'OCCITANE Group
  • NAOS
  • Yves Rocher France
  • Mary Kay Inc.
  • Nutraceutical Corporation
  • Guerlain
  • Celtic Seaweed Bath Products Ltd.
  • Weleda AG
  • Avon Products Inc.
  • Oriflame Holding AG

第 13 章附錄

  • 縮寫
  • 來源和參考
  • 相關報導
目錄
Product Code: LS10343

From $194.4 billion in 2020, the global market size for anti-aging is set to cross $422.8 billion by 2030, at an 8.6% CAGR between 2021 and 2030 (forecast period). The key factors driving this growth would be the increase in the awareness on the available products via conferences and seminars, growth in the medical tourism sector, increase in the number of anti-aging cosmetic procedures, and rise in the disposable income worldwide.

The anti-aging market was badly affected during the COVID-19 pandemic, as manufacturing plants remained shut during much of the lockdown period, in compliance with government norms. Similarly, international trade, especially of non-essential goods, was prohibited or limited, thereby reducing the product supply. In addition, the closed cosmetic centers, spas, and dermatology departments at hospitals reduced the demand for the devices.

In 2020, North America generated the highest revenue in the anti-aging market on account of the rising volume of non-surgical cosmetic treatments, increasing skincare product awareness, and surging volume of anti-aging treatments in Canada and the U.S.

The fastest anti-aging market growth is likely to be seen in Asia-Pacific (APAC) till 2030 due to the rising volume of cosmetic procedures, in part due to the swift urbanization. Moreover, the growing geriatric population is propelling the market in the region as it is increasingly seeking treatment for age-related issues. The World Population Ageing 2019 report of the United Nations (UN) expects the population of people 65 years and older in Asia to surge from 395.3 million in 2019 to 954.7 million by 2050.

Product Launches Characterize Market Competition:

In order to target more customers, players in the anti-aging market are launching new products.

For instance, in March 2020, Stellar M22 was launched by Lumenis Ltd. to offer better energy-based skincare treatments. This next-generation, multi-application platform features an improved user interface and large screen for higher comfort and to allow one to view the treatment from a distance.

The most-significant players in the global anti-aging market are The Procter & Gamble (P&G) Company, Hologic Inc., Nu Skin Enterprises Inc., Unilever Group, Galderma SA, Pierre Fabre S.A, Shiseido Company Limited, Home Skinovations Ltd., and Candela Corporation.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Treatment
    • 1.3.3 Market Segmentation by Demography
    • 1.3.4 Market Segmentation by Region
    • 1.3.5 Analysis Period
    • 1.3.6 Market Data Reporting Unit
      • 1.3.6.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Anti-wrinkle
        • 4.1.1.1.1 Topical products
        • 4.1.1.1.2 Botox
        • 4.1.1.1.3 Dermal fillers
      • 4.1.1.2 Hair color
      • 4.1.1.3 UV absorption
      • 4.1.1.4 Anti-stretch mark
      • 4.1.1.5 Others
    • 4.1.2 By Treatment
      • 4.1.2.1 Hair restoration
      • 4.1.2.2 Anti-pigmentation
      • 4.1.2.3 Adult acne therapy
      • 4.1.2.4 Breast augmentation
      • 4.1.2.5 Liposuction
      • 4.1.2.6 Chemical peel
      • 4.1.2.7 Others
    • 4.1.3 By Demography
      • 4.1.3.1 Generation X
      • 4.1.3.2 Baby boomers
      • 4.1.3.3 Generation Y
      • 4.1.3.4 Generation Z
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing inclination of consumers toward easy-to-use, at-home anti-aging devices
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing awareness through seminars and conferences
      • 4.2.2.2 Surge in geriatric population
      • 4.2.2.3 Rising disposable income
      • 4.2.2.4 Advancements in technology
      • 4.2.2.5 Growing medical tourism industry
      • 4.2.2.6 Increasing volume of anti-aging cosmetic procedures
      • 4.2.2.7 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High cost of anti-aging devices
      • 4.2.3.2 Stringent regulatory requirements
      • 4.2.3.3 Risks and side-effects associated with the use of anti-aging devices
      • 4.2.3.4 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Unmet need for minimally or non-invasive treatments
      • 4.2.4.2 Rising use of social networking and e-commerce platforms
  • 4.3 Impact of COVID-19
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes
  • 4.5 Target Audience - Demographics
    • 4.5.1 Total Population, By Gender
    • 4.5.2 Prevalence of Acne Vulgaris, By Gender
    • 4.5.3 Total Population, By Age
    • 4.5.4 Prevalence of Acne Vulgaris, By Age
    • 4.5.5 Target Population for Skin Rejuvenation and Anti-Aging Products, By Age
    • 4.5.6 Male Target Population for Skin Rejuvenation and Anti-Aging Products, By Age
    • 4.5.7 Female Target Population for Skin Rejuvenation and Anti-Aging Products, By Age
  • 4.6 Regulatory Framework Analysis
    • 4.6.1 North America
    • 4.6.2 Europe
    • 4.6.3 APAC
    • 4.6.4 LATAM
    • 4.6.5 MEA
  • 4.7 Number of Patients Visited Hospitals for Anti-Aging Procedures (2020)
    • 4.7.1 U.S.
    • 4.7.2 Canada
    • 4.7.3 Germany
    • 4.7.4 France
    • 4.7.5 U.K.
    • 4.7.6 Italy
    • 4.7.7 Spain
    • 4.7.8 Switzerland
    • 4.7.9 Japan
    • 4.7.10 Chinese
    • 4.7.11 India
    • 4.7.12 South Korea
    • 4.7.13 Taiwan
    • 4.7.14 Singapore
    • 4.7.15 Malaysia
    • 4.7.16 Brazil
    • 4.7.17 Mexico
    • 4.7.18 Saudi Arabia
  • 4.8 Type of Anti-Aging Procedures Offered by Hospitals and their Costs
  • 4.9 Business Model Adopted by Hospitals
  • 4.10 Anti-Aging Programs/Packages Offered by Hospitals

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Anti-Wrinkle Market, by Type
  • 5.2 By Treatment
  • 5.3 By Demography
  • 5.4 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Anti-Wrinkle Market, by Type
  • 6.2 By Treatment
  • 6.3 By Demography
  • 6.4 By Country
    • 6.4.1 U.S. Anti-Aging Market
      • 6.4.1.1 By product
        • 6.4.1.1.1 Anti-wrinkle market, by type
      • 6.4.1.2 By treatment
      • 6.4.1.3 By demography
    • 6.4.2 Canada Anti-Aging Market
      • 6.4.2.1 By product
        • 6.4.2.1.1 Anti-wrinkle market, by type
      • 6.4.2.2 By treatment
      • 6.4.2.3 By demography

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Anti-Wrinkle Market, by Type
  • 7.2 By Treatment
  • 7.3 By Demography
  • 7.4 By Country
    • 7.4.1 Germany Anti-Aging Market
      • 7.4.1.1 By product
        • 7.4.1.1.1 Anti-wrinkle market, by type
      • 7.4.1.2 By treatment
      • 7.4.1.3 By demography
    • 7.4.2 U.K. Anti-Aging Market
      • 7.4.2.1 By product
        • 7.4.2.1.1 Anti-wrinkle market, by type
      • 7.4.2.2 By treatment
      • 7.4.2.3 By demography
    • 7.4.3 France Anti-Aging Market
      • 7.4.3.1 By product
        • 7.4.3.1.1 Anti-wrinkle market, by type
      • 7.4.3.2 By treatment
      • 7.4.3.3 By demography
    • 7.4.4 Italy Anti-Aging Market
      • 7.4.4.1 By product
        • 7.4.4.1.1 Anti-wrinkle market, by type
      • 7.4.4.2 By treatment
      • 7.4.4.3 By demography
    • 7.4.5 Spain Anti-Aging Market
      • 7.4.5.1 By product
        • 7.4.5.1.1 Anti-wrinkle market, by type
      • 7.4.5.2 By treatment
      • 7.4.5.3 By demography
    • 7.4.6 Switzerland Anti-Aging Market
      • 7.4.6.1 By product
        • 7.4.6.1.1 Anti-wrinkle market, by type
      • 7.4.6.2 By treatment
      • 7.4.6.3 By demography

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Anti-Wrinkle Market, by Type
  • 8.2 By Treatment
  • 8.3 By Demography
  • 8.4 By Country
    • 8.4.1 Japan Anti-Aging Market
      • 8.4.1.1 By product
        • 8.4.1.1.1 Anti-wrinkle market, by type
      • 8.4.1.2 By treatment
      • 8.4.1.3 By demography
    • 8.4.2 China Anti-Aging Market
      • 8.4.2.1 By product
        • 8.4.2.1.1 Anti-wrinkle market, by type
      • 8.4.2.2 By treatment
      • 8.4.2.3 By demography
    • 8.4.3 India Anti-Aging Market
      • 8.4.3.1 By product
        • 8.4.3.1.1 Anti-wrinkle market, by type
      • 8.4.3.2 By treatment
      • 8.4.3.3 By demography
    • 8.4.4 South Korea Anti-Aging Market
      • 8.4.4.1 By product
        • 8.4.4.1.1 Anti-wrinkle market, by type
      • 8.4.4.2 By treatment
      • 8.4.4.3 By demography
    • 8.4.5 Taiwan Anti-Aging Market
      • 8.4.5.1 By product
        • 8.4.5.1.1 Anti-wrinkle market, by type
      • 8.4.5.2 By treatment
      • 8.4.5.3 By demography
    • 8.4.6 Singapore Anti-Aging Market
      • 8.4.6.1 By product
        • 8.4.6.1.1 Anti-wrinkle market, by type
      • 8.4.6.2 By treatment
      • 8.4.6.3 By demography
    • 8.4.7 Malaysia Anti-Aging Market
      • 8.4.7.1 By product
        • 8.4.7.1.1 Anti-wrinkle market, by type
      • 8.4.7.2 By treatment
      • 8.4.7.3 By demography

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Anti-Wrinkle Market, by Type
  • 9.2 By Treatment
  • 9.3 By Demography
  • 9.4 By Country
    • 9.4.1 Brazil Anti-Aging Market
      • 9.4.1.1 By product
        • 9.4.1.1.1 Anti-wrinkle market, by type
      • 9.4.1.2 By treatment
      • 9.4.1.3 By demography
    • 9.4.2 Mexico Anti-Aging Market
      • 9.4.2.1 By product
        • 9.4.2.1.1 Anti-wrinkle market, by type
      • 9.4.2.2 By treatment
      • 9.4.2.3 By demography

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Anti-Wrinkle Market, by Type
  • 10.2 By Treatment
  • 10.3 By Demography
  • 10.4 By Country
    • 10.4.1 Saudi Arabia Anti-Aging Market
      • 10.4.1.1 By product
        • 10.4.1.1.1 Anti-wrinkle market, by type
      • 10.4.1.2 By treatment
      • 10.4.1.3 By demography

Chapter 11. Competitive Landscape

  • 11.1 List of Players and Their Offerings
  • 11.2 Product Benchmarking of Key Players
  • 11.3 Strategic Developments of Key Players
    • 11.3.1 Mergers and Acquisitions
    • 11.3.2 Facility Expansions
    • 11.3.3 Product Launches and Approvals
    • 11.3.4 Partnerships and Collaborations
    • 11.3.5 Other Developments

Chapter 12. Company Profiles

  • 12.1 The Procter & Gamble Company
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Nu Skin Enterprises Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Hologic Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Unilever Group
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Pierre Fabre S.A
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 Galderma SA
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
  • 12.7 Shiseido Company Limited
    • 12.7.1 Business overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Candela Corporation
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
  • 12.9 Home Skinovations Ltd.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
  • 12.10 Allergan plc
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
    • 12.10.3 Key Financial Summary
  • 12.11 The Estee Lauder Companies Inc.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 Johnson & Johnson
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 Beiersdorf AG
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
    • 12.13.3 Key Financial Summary
  • 12.14 L'Oreal SA
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary
  • 12.15 Orlane S.A.
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
  • 12.16 Age Sciences Inc.
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
  • 12.17 Coty Inc.
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
    • 12.17.3 Key Financial Summary
  • 12.18 Alma Lasers Ltd.
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
  • 12.19 Lumenis Ltd.
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings
  • 12.20 Panasonic Corporation
    • 12.20.1 Business Overview
    • 12.20.2 Product and Service Offerings
    • 12.20.3 Key Financial Summary
  • 12.21 TRIA Beauty Inc.
    • 12.21.1 Business Overview
    • 12.21.2 Product and Service Offerings
  • 12.22 Carol Cole Company Inc.
    • 12.22.1 Business Overview
    • 12.22.2 Product and Service Offerings
  • 12.23 YA-MAN LTD.
    • 12.23.1 Business Overview
    • 12.23.2 Product and Service Offerings
  • 12.24 MTG Co. Ltd.
    • 12.24.1 Business Overview
    • 12.24.2 Product and Service Offerings
  • 12.25 Koninklijke Philips N.V.
    • 12.25.1 Business Overview
    • 12.25.2 Product and Service Offerings
    • 12.25.3 Key Financial Summary
  • 12.26 LightStim
    • 12.26.1 Business Overview
    • 12.26.2 Product and Service Offerings
  • 12.27 Spectrum Brands Holdings Inc.
    • 12.27.1 Business Overview
    • 12.27.2 Product and Service Offerings
    • 12.27.3 Key Financial Summary
  • 12.28 Conair Corporation
    • 12.28.1 Business Overview
    • 12.28.2 Product and Service Offerings
  • 12.29 Amorepacific Corporation
    • 12.29.1 Business Overview
    • 12.29.2 Product and Service Offerings
    • 12.29.3 Key Financial Summary
  • 12.30 Project E Beauty
    • 12.30.1 Business Overview
    • 12.30.2 Product and Service Offerings
  • 12.31 Dr. Dennis Gross Skincare LLC
    • 12.31.1 Business Overview
    • 12.31.2 Product and Service Offerings
  • 12.32 Beauty Bioscience Inc.
    • 12.32.1 Business Overview
    • 12.32.2 Product and Service Offerings
  • 12.33 FOREO AB
    • 12.33.1 Business Overview
    • 12.33.2 Product and Service Offerings
  • 12.34 Cyden Limited
    • 12.34.1 Business Overview
    • 12.34.2 Product and Service Offerings
  • 12.35 Jeisys Medical Inc.
    • 12.35.1 Business Overview
    • 12.35.2 Product and Service Offerings
  • 12.36 Imdad LLC
    • 12.36.1 Business Overview
    • 12.36.2 Product and Service Offerings
  • 12.37 Clarins Group
    • 12.37.1 Business Overview
    • 12.37.2 Product and Service Offerings
  • 12.38 L'OCCITANE Group
    • 12.38.1 Business Overview
    • 12.38.2 Product and Service Offerings
    • 12.38.3 Key Financial Summary
  • 12.39 NAOS
    • 12.39.1 Business Overview
    • 12.39.2 Product and Service Offerings
  • 12.40 Yves Rocher France
    • 12.40.1 Business Overview
    • 12.40.2 Product and Service Offerings
  • 12.41 Mary Kay Inc.
    • 12.41.1 Business Overview
    • 12.41.2 Product and Service Offerings
  • 12.42 Nutraceutical Corporation
    • 12.42.1 Business Overview
    • 12.42.2 Product and Service Offerings
  • 12.43 Guerlain
    • 12.43.1 Business Overview
    • 12.43.2 Product and Service Offerings
  • 12.44 Celtic Seaweed Bath Products Ltd.
    • 12.44.1 Business Overview
    • 12.44.2 Product and Service Offerings
  • 12.45 Weleda AG
    • 12.45.1 Business Overview
    • 12.45.2 Product and Service Offerings
    • 12.45.3 Key Financial Summary
  • 12.46 Avon Products Inc.
    • 12.46.1 Business Overview
    • 12.46.2 Product and Service Offerings
    • 12.46.3 Key Financial Summary
  • 12.47 Oriflame Holding AG
    • 12.47.1 Business Overview
    • 12.47.2 Product and Service Offerings
    • 12.47.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL ANTI-AGING MARKET SUMMARY
  • FIG 9 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION IN MAJOR REGIONS (2019 AND 2050)
  • FIG 10 AVERAGE PERCENTAGE OF MEDICAL TOURISTS WHO AVAILED ANTI-AGING PROCEDURES IN DIFFERENT COUNTRIES (2019)
  • FIG 11 PORTER'S FIVE FORCES ANALYSIS
  • FIG 12 SNAPSHOT OF GLOBAL ANTI-AGING MARKET (2020)
  • FIG 13 GLOBAL ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 14 GLOBAL ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 15 GLOBAL ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 16 WORLDWIDE MAJOR MARKETS FOR ANTI-AGING PRODUCTS
  • FIG 17 NORTH AMERICA ANTI-AGING MARKET SNAPSHOT
  • FIG 18 PLASTIC SURGERIES AND COSMETIC SURGERIES PERFORMED IN THE U.S. (2019)
  • FIG 19 NORTH AMERICA ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 20 NORTH AMERICA ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 21 NORTH AMERICA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 22 NORTH AMERICA ANTI-AGING MARKET, BY COUNTRY, $M (2015-2030)
  • FIG 23 EUROPE ANTI-AGING MARKET SNAPSHOT
  • FIG 24 EUROPE ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 25 EUROPE ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 26 EUROPE ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 27 EUROPE ANTI-AGING MARKET, BY COUNTRY, $M (2015-2030)
  • FIG 28 APAC ANTI-AGING MARKET SNAPSHOT
  • FIG 29 APAC ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 30 APAC ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 31 APAC ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 32 APAC ANTI-AGING MARKET, BY COUNTRY, $M (2015-2030)
  • FIG 33 LATAM ANTI-AGING MARKET SNAPSHOT
  • FIG 34 LATAM ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 35 LATAM ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 36 LATAM ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 37 LATAM ANTI-AGING MARKET, BY COUNTRY, $M (2015-2030)
  • FIG 38 MEA ANTI-AGING MARKET SNAPSHOT
  • FIG 39 MEA ANTI-AGING MARKET, BY PRODUCT, $M (2015-2030)
  • FIG 40 MEA ANTI-AGING MARKET, BY TREATMENT, $M (2015-2030)
  • FIG 41 MEA ANTI-AGING MARKET, BY DEMOGRAPHY, $M (2015-2030)
  • FIG 42 MEA ANTI-AGING MARKET, BY COUNTRY, $M (2015-2030)
  • FIG 43 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 44 THE PROCTER & GAMBLE COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 45 NU SKIN ENTERPRISES INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)
  • FIG 46 HOLOGIC INC. - REVENUE SPLIT BY PRODUCT SEGMENT AND GEOGRAPHY (2020)
  • FIG 47 UNILEVER GROUP - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 48 PIERRE FABRE S.A - REVENUE SPLIT BY SEGMENT (2020)
  • FIG 49 SHISEIDO COMPANY LIMITED - REVENUE SPLIT BY BRAND CATEGORY AND GEOGRAPHY (2020)
  • FIG 50 ALLERGAN PLC - REVENUE SPLIT BY SEGMENT (2019)
  • FIG 51 THE ESTEE LAUDER COMPANIES INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)
  • FIG 52 JOHNSON & JOHNSON - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 53 BEIERSDORF AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 54 L'OREAL SA - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
  • FIG 55 COTY INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)
  • FIG 56 PANASONIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 57 KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 58 SPECTRUM BRANDS HOLDINGS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 59 AMOREPACIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 60 L'OCCITANE GROUP - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 61 WELEDA AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2020)
  • FIG 62 AVON PRODUCTS INC. - REVENUE SPLIT BY GEOGRAPHY (2020)
  • FIG 63 ORIFLAME HOLDING AG. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)